Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

An integrated experimental-computational approach for predicting virulence in New Zealand white rabbits and humans following inhalation exposure to Bacillus anthracis spores.

Hess BM, Thomas DG, Weber TJ, Hutchison JR, Straub TM, Bruckner-Lea CJ, Powell JD, Kabilan S, Corley RA.

PLoS One. 2019 Jul 1;14(7):e0219160. doi: 10.1371/journal.pone.0219160. eCollection 2019.

2.

Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled Period.

Portale AA, Carpenter TO, Brandi ML, Briot K, Cheong HI, Cohen-Solal M, Crowley R, Jan De Beur S, Eastell R, Imanishi Y, Imel EA, Ing S, Ito N, Javaid M, Kamenicky P, Keen R, Kubota T, Lachmann R, Perwad F, Pitukcheewanont P, Ralston SH, Takeuchi Y, Tanaka H, Weber TJ, Yoo HW, Zhang L, Theodore-Oklota C, Mealiffe M, San Martin J, Insogna K.

Calcif Tissue Int. 2019 Sep;105(3):271-284. doi: 10.1007/s00223-019-00568-3. Epub 2019 Jun 4.

PMID:
31165191
3.

Stable Acinar Progenitor Cell Model Identifies Treacle-Dependent Radioresistance.

Weber TJ, Qian WJ, Smith JN, Gritsenko MA, Hu D, Chrisler WB, Timchalk C.

Radiat Res. 2019 Aug;192(2):135-144. doi: 10.1667/RR15342.1. Epub 2019 May 29.

PMID:
31141469
4.

Tenofovir Has Minimal Effect on Biomarkers of Bone Health in Youth with HIV Receiving Initial Antiretroviral Therapy.

Kim-Chang JJ, Wilson L, Chan C, Fischer B, Venturi G, Goodenow MM, Aldrovandi G, Weber TJ, Sleasman JW; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

AIDS Res Hum Retroviruses. 2019 Aug;35(8):746-754. doi: 10.1089/AID.2018.0270. Epub 2019 Jun 27.

PMID:
31115244
5.

Evaluation of non-invasive biomonitoring of 2,4-Dichlorophenoxyacetic acid (2,4-D) in saliva.

Carver ZA, Han AA, Timchalk C, Weber TJ, Tyrrell KJ, Sontag RL, Luders T, Chrisler WB, Weitz KK, Smith JN.

Toxicology. 2018 Dec 1;410:171-181. doi: 10.1016/j.tox.2018.08.003. Epub 2018 Aug 16.

6.

Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density.

Weber TJ, Koh J, Thomas SM, Hogue JA, Scheri RP, Roman SA, Sosa JA.

Metabolism. 2017 Sep;74:22-31. doi: 10.1016/j.metabol.2017.06.004. Epub 2017 Jun 19.

7.

Case series: Odontohypophosphatasia or missed diagnosis of childhood/adult-onset hypophosphatasia? - Call for a long-term follow-up of premature loss of primary teeth.

Mori M, DeArmey SL, Weber TJ, Kishnani PS.

Bone Rep. 2016 Aug 26;5:228-232. doi: 10.1016/j.bonr.2016.08.004. eCollection 2016 Dec.

8.

Predicting Transport of 3,5,6-Trichloro-2-Pyridinol Into Saliva Using a Combination Experimental and Computational Approach.

Smith JN, Carver ZA, Weber TJ, Timchalk C.

Toxicol Sci. 2017 Jun 1;157(2):438-450. doi: 10.1093/toxsci/kfx055.

PMID:
28402492
9.

Employee Embezzlement.

Weber TJ, Howlett CA.

J Mich Dent Assoc. 2016 Dec;98(12):34-37. No abstract available.

PMID:
30721593
10.

Burden of disease in adult patients with hypophosphatasia: Results from two patient-reported surveys.

Weber TJ, Sawyer EK, Moseley S, Odrljin T, Kishnani PS.

Metabolism. 2016 Oct;65(10):1522-30. doi: 10.1016/j.metabol.2016.07.006. Epub 2016 Jul 19.

PMID:
27621187
11.

EMPLOYEE EMBEZZLEMENT.

Weber TJ, Howlett CA.

Pa Dent J (Harrisb). 2016 May-Jun;83(3):16-9. No abstract available.

PMID:
27434968
12.

Employee Restrictive Covenants in the Practice of Dentistry.

Weber TJ.

Pa Dent J (Harrisb). 2016 Jul-Aug;83(4):30-4. No abstract available.

PMID:
30462891
13.

Battle of the sex steroids in the male skeleton: and the winner is....

Weber TJ.

J Clin Invest. 2016 Mar 1;126(3):829-32. doi: 10.1172/JCI85006. Epub 2016 Feb 22.

14.

Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia.

Ruppe MD, Zhang X, Imel EA, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey JS, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO.

Bone Rep. 2016 May 13;5:158-162. doi: 10.1016/j.bonr.2016.05.004. eCollection 2016 Dec.

15.

Non-invasive saliva human biomonitoring: development of an in vitro platform.

Weber TJ, Smith JN, Carver ZA, Timchalk C.

J Expo Sci Environ Epidemiol. 2017 Jan;27(1):72-77. doi: 10.1038/jes.2015.74. Epub 2015 Nov 11.

PMID:
26555474
16.

Computational strategy for quantifying human pesticide exposure based upon a saliva measurement.

Timchalk C, Weber TJ, Smith JN.

Front Pharmacol. 2015 May 27;6:115. doi: 10.3389/fphar.2015.00115. eCollection 2015. Review.

17.

Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.

Zhang X, Imel EA, Ruppe MD, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey J, Glorieux FH, Portale AA, Insogna K, Carpenter TO, Peacock M.

J Clin Pharmacol. 2016 Feb;56(2):176-85. doi: 10.1002/jcph.570. Epub 2015 Aug 11.

18.

Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23.

Imel EA, Zhang X, Ruppe MD, Weber TJ, Klausner MA, Ito T, Vergeire M, Humphrey JS, Glorieux FH, Portale AA, Insogna K, Peacock M, Carpenter TO.

J Clin Endocrinol Metab. 2015 Jul;100(7):2565-73. doi: 10.1210/jc.2015-1551. Epub 2015 Apr 28. Erratum in: J Clin Endocrinol Metab. 2017 Jan 1;102(1):336.

19.

Data integration reveals key homeostatic mechanisms following low dose radiation exposure.

Tilton SC, Matzke MM, Sowa MB, Stenoien DL, Weber TJ, Morgan WF, Waters KM.

Toxicol Appl Pharmacol. 2015 May 15;285(1):1-11. doi: 10.1016/j.taap.2015.01.019. Epub 2015 Feb 2.

PMID:
25655199
20.

Impaired osteoblast differentiation in annexin A2- and -A5-deficient cells.

Genetos DC, Wong A, Weber TJ, Karin NJ, Yellowley CE.

PLoS One. 2014 Sep 15;9(9):e107482. doi: 10.1371/journal.pone.0107482. eCollection 2014.

Supplemental Content

Loading ...
Support Center